Literature DB >> 15039056

The use of different multiplex PCRs for twin zygosity determination and its application in forensic trace analysis.

Nicole von Wurmb-Schwark1, Thorsten Schwark, Lene Christiansen, Delia Lorenz, Manfred Oehmichen.   

Abstract

STR typing becomes more and more valuable for different approaches of science. It revolutionized determining of zygosity in twin research and it is very often the only possibility for discrimination in forensic trace analysis. In this study 55 twin pairs from Denmark were genetically investigated to determine their zygosity. For analysis two multiplex PCR kits, the AmpFlSTR Identifiler kit, which comprises 15 loci plus the amelogenin gender determination and the Powerplex ES kit with eight different loci were employed. For a forensic approach every twin pair was regarded as being a forensic trace analysis, i.e. suspect or victim/biological trace and then we determined the security and precision with that a match of genetic patterns or an exclusion could be observed. Sixty percent of the twin pairs were di- and 40% monozygotic. There were no differences in zygosity determination between the two multiplex kits. The lowest number of exclusions by determining dizygosity was four loci for the Identifiler and three for Powerplex ES kit, the highest was 13 (Identifiler) and eight (Powerplex). It could be shown that the highly discriminative multiplex PCR kits gave matching probabilities of over 99.999999% (calculation based on data for unrelated individuals) even when only five or six STRs could be determined (assuming a trace analysis with some non-detectable STRs and therefore an incomplete genetic pattern). No questionable results regarding zygosity of the twin pairs were obtained even when only eight loci (using the Powerplex ES kit) were investigated. The simulated forensic results showed that matching probabilities should always be handled with care to not possibly come to wrong conclusions concerning the origin of the biological trace.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039056     DOI: 10.1016/j.legalmed.2003.12.002

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  6 in total

1.  Optimization of short tandem repeats (STR) typing method and allele frequency of 8 STR markers in referring to forensic medicine of Semnan Province.

Authors:  M Eskandarion; M Najafi; M Akbari Eidgahi; A Alipour Tabrizi; T Golmohamadi
Journal:  J Med Life       Date:  2015

2.  Differences of DNA methylation profiles between monozygotic twins' blood samples.

Authors:  Chengtao Li; Shumin Zhao; Na Zhang; Suhua Zhang; Yiping Hou
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

3.  Quantitative ultrasound of the hand phalanges in a cohort of monozygotic twins: influence of genetic and environmental factors.

Authors:  G Guglielmi; F de Terlizzi; I Torrente; R Mingarelli; B Dallapiccola
Journal:  Skeletal Radiol       Date:  2005-07-06       Impact factor: 2.199

4.  Are Epigenetic Factors Implicated in Chronic Widespread Pain?

Authors:  Andrea Burri; Zoya Marinova; Mark D Robinson; Brigitte Kühnel; Melanie Waldenberger; Simone Wahl; Sonja Kunze; Christian Gieger; Gregory Livshits; Frances Williams
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

5.  Intra-Monozygotic Twin Pair Discordance and Longitudinal Variation of Whole-Genome Scale DNA Methylation in Adults.

Authors:  Na Zhang; Shumin Zhao; Su-Hua Zhang; Jinzhong Chen; Daru Lu; Min Shen; Chengtao Li
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

6.  Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study.

Authors:  Oliver van Hecke; Lynne J Hocking; Nicola Torrance; Archie Campbell; Sandosh Padmanabhan; David J Porteous; Andrew M McIntosh; Andrea V Burri; Haruka Tanaka; Frances M K Williams; Blair H Smith
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.